Cancer-killing virus boosts immunotherapy in hard-to-treat cancer 15 Jun 2019 Combining a cancer-killing virus with immunotherapy could effectively treat advanced cancers that affect the limbs, a new study reveals. Find out more Show/Hide
ASCO 2019: Immunotherapy better than aggressive chemotherapy as first treatment option for recurrent head and neck cancer 04 Jun 2019 Immunotherapy used with chemotherapy or on its own is a better first-line treatment for people with head and neck cancer that has returned than standard aggressive chemotherapy, new clinical trial results show. Find out more Show/Hide
Immunotherapy keeps some patients with advanced head and neck cancer alive for more than three years 30 Nov 2018 A new immunotherapy can greatly extend the lives of a proportion of people with advanced head and neck cancer, with some living for three years or more, a major new clinical trial reports. Find out more Show/Hide
ESMO 2018: Immunotherapy effective as first-line treatment for advanced head and neck cancer 22 Oct 2018
Viral gene therapy could improve results from breast reconstruction surgery after cancer treatment 24 Jan 2018
Breakthrough for advanced head and neck cancer patients as nivolumab made available on the Cancer Drugs Fund 13 Oct 2017